| For: | Wang J, Gao YS, Xu K, Li XD. Combination of atezolizumab and chidamide to maintain long-term remission in refractory metastatic extranodal natural killer/T-cell lymphoma: A case report. World J Clin Cases 2022; 10(5): 1609-1616 [PMID: 35211600 DOI: 10.12998/wjcc.v10.i5.1609] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i5/1609.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Shuhui Zhuang, Zhaobo Yang, Zhuangzhuang Cui, Yuanyuan Zhang, Fengyuan Che. Epigenetic alterations and advancement of lymphoma treatment. Annals of Hematology 2024; 103(5): 1435 doi: 10.1007/s00277-023-05395-z
|
| 3 |
Zheng Yan, Shuna Yao, Zhizhong Wang, Wenping Zhou, Zhihua Yao, Yanyan Liu. Treatment of extranodal NK/T-cell lymphoma: From past to future. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1088685
|
| 4 |
Ajay Major, Pierluigi Porcu, Bradley M. Haverkos. Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma. Cancers 2023; 15(5): 1366 doi: 10.3390/cancers15051366
|
| 5 |
Jianing Wang, Junbao Xu, Xiaoqing Ma, Qianqian Wang, Zhengchun Liu, Xuecheng Zhang, Yongqiang Wei, Shuai Wang, Chunjing Liang, Peiling Zhai. Epigenetic therapy combined with radiotherapy reshapes tumor immune response. Experimental and Molecular Pathology 2026; 146: 105040 doi: 10.1016/j.yexmp.2026.105040
|